开设账户
模拟账户
关于我们
即时报价及新闻
市场分析
财经日历
每日市场分析
交易平台
下载及介绍
使用教学
交易细则
各项细则
资金提存
推广和资讯
常见问题
联络我们
繁
简
EN
客户登入
开设账户
模拟账户
繁
简
EN
客户登入
开设账户
模拟账户
关于我们
上志国际介绍
上志国际优势
即时报价及新闻
即时报价
即时新闻
市场分析
财经日历
市场分析
交易平台
平台特点
平台教学
交易细则
各项细则
资金提存
推广和资讯
常见问题
联络我们
关于我们
交易细则
贵金属市场
交易平台
市场分析
推广和资讯
常见问题
联络我们
繁
简
EN
日本首相高市早苗:加拿大原油今天抵达日本,这是自中东局势恶化以来的首次。
2026-08-12
日本首相高市早苗:加拿大原油今天抵达日本,这是自中东局势恶化以来的首次。
返回
其他消息
2026-08-11
Qatar foreign ministry spokesman said negotiations are at a critical stage and the ministry supports all efforts to de-escalate.
Qatar foreign ministry spokesman said negotiations are at a critical stage and the ministry supports all efforts to de-escalate.
2026-08-11
China NMPA, via priority review, has conditionally approved a Class 1 innovative drug, Tengogetinib tablets (brand Jientai), developed by Yaojie Ankang (Nanjing) Technology Co., Ltd. Indication: adults with advanced, metastatic or unresectable cholangiocarcinoma harboring FGFR2 fusions or rearrangements who have previously received systemic therapy and an FGFR inhibitor. The approval provides a new treatment option for this defined patient group.
China NMPA, via priority review, has conditionally approved a Class 1 innovative drug, Tengogetinib tablets (brand Jientai), developed by Yaojie Ankang (Nanjing) Technology Co., Ltd. Indication: adults with advanced, metastatic or unresectable cholangiocarcinoma harboring FGFR2 fusions or rearrangements who have previously received systemic therapy and an FGFR inhibitor. The approval provides a new treatment option for this defined patient group.
Chat with us
, powered by
LiveChat